A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

Sponsor
Novo Nordisk A/S
Study ID
NCT02077946
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • liraglutide — DRUG
    No treatment given.
  • sitagliptin — DRUG
    No treatment given.

Study Details

This trial is conducted in Europe. The aim of this study is to investigate a retrospective database assessment of clinical effectiveness in type 2 diabetes patients treated with liraglutide from primary care centers in Sweden.

Key Dates

Start date
Feb 10, 2014
Status verified
May 2017
Primary completion
Sep 3, 2014
Completion
Sep 3, 2014

Study Design

Enrollment
1,059 participants (actual)

Arms

  • Arm: Liraglutide / Sitagliptin

Primary Outcome Measure

Percent (%) of patients achieving at least 1 %-point HbA1c (glycosylated haemoglobin) reduction [ Time Frame: Day 0, Day 180 ]

Related Studies